In vitro application of hinokitiol significantly attenuated the proliferation of HCC cell lines in a dose-dependent manner while downregulating the protein levels of UHRF1, GLI1, CD44, and CD133 (Fig. 6E and S7A). Here, CD44 is linked to hepatocellular carcinoma.